On August 05, 2022, in order to better implement the “Healthy China 2030” Plan and following the deployment of the State Council to promote the construction of a tiered diagnosis and treatment system, under the guidance of relevant authorities of the National Health Commission, the “Spark Plan-Standardized Diagnosis and Treatment of Drug-induced Liver Diseases in 100 Counties” project, jointly initiated by the Technical Committee for the Prevention and Treatment of DILI of the China Medical Biotechnology Association, the Drug-induced Liver Disease Group of the Hepatology Branch of the Chinese Medical Association, and the China Medical Tribune, and supported by Beijing Union Pharmaceutical Factory LTD, was launched in Beijing. This project belongs to the “Community Standardized Diagnosis and Tr...